Eosinophilia-myalgia syndrome, toxic-oil syndrome, and diffuse fasciitis with eosinophilia

Curr Opin Rheumatol. 1994 Nov;6(6):642-9. doi: 10.1097/00002281-199411000-00016.

Abstract

Eosinophilia-myalgia syndrome, a recently described illness, reached epidemic proportions in 1989 and was linked to the ingestion of L-tryptophan containing trace amounts of several contaminants. Eosinophilia-myalgia syndrome shares many clinical and pathologic similarities with toxic-oil syndrome, an epidemic linked to the ingestion of adulterated cooking oil that occurred in Spain in 1981, and to diffuse fasciitis with eosinophilia, a condition first described in 1974. Over the past year, much work has been done in understanding the etiology and pathogenesis of eosinophilia-myalgia syndrome and toxic-oil syndrome. Follow-up data detailing the long-term sequelae and mortality rates for these two conditions are becoming available. The results from these studies are reviewed in this paper.

Publication types

  • Review

MeSH terms

  • Brassica*
  • Eosinophilia / etiology*
  • Eosinophilia / pathology
  • Eosinophilia / therapy
  • Eosinophilia-Myalgia Syndrome / epidemiology
  • Eosinophilia-Myalgia Syndrome / etiology*
  • Eosinophilia-Myalgia Syndrome / pathology
  • Eosinophilia-Myalgia Syndrome / therapy
  • Fasciitis / etiology*
  • Fasciitis / pathology
  • Fasciitis / therapy
  • Fatty Acids, Monounsaturated
  • Female
  • Humans
  • Male
  • Plant Oils / poisoning*
  • Rapeseed Oil
  • Risk Factors
  • Syndrome

Substances

  • Fatty Acids, Monounsaturated
  • Plant Oils
  • Rapeseed Oil